Epigenetic Modifications of Diabetes Mellitus Type I
Withdrawn
- Conditions
- Type I Diabetes
- Registration Number
- NCT01623388
- Lead Sponsor
- Scripps Translational Science Institute
- Brief Summary
This research is being done to find out if significant changes in blood glucose cause bad outcomes in patients with diabetes.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- 18-65 years old
- Diagnosis of Type I diabetes
- Willing to wear continuous blood glucose monitor as specified in protocol
Exclusion Criteria
- Pregnant or planning to become pregnant during the study
Healthy control group Inclusion:
- 18-65 years old
- Willing to wear continuous blood glucose monitor as specified in protocol
Exclusion:
- Pregnant or planning to become pregnant during the study
- Diagnosis of Type I or II Diabetes
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluate blood sugar variability in Type I diabetics for differences in epigenetic signatures between Type I diabetics with little glycemic variability as compared to those with more pronounced glycemic changes. 7 days
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Scripps
🇺🇸San Diego, California, United States
Scripps🇺🇸San Diego, California, United States